Kairos Pharma (KAPA) Stock Chart & Stock Price History $1.22 0.00 (0.00%) Closing price 04:10 PM EasternExtended Trading$1.24 +0.02 (+1.64%) As of 06:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartHeadlinesOwnershipSEC FilingsShort InterestBuy This Stock Kairos Pharma Stock Price Performance The Kairos Pharma (KAPA) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 19.74%. In the past month, the stock has decreased 29.07%, reflecting recent market activity. As of the latest close, Kairos Pharma traded at $1.22 with a market cap of $25.30 million and volume of 452,727 shares. Receive KAPA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+6.09%1 Month Performance-29.07%3 Month Performance+84.01%Year-To-Date Performance-19.74% KAPA Stock Chart for Tuesday, October, 7, 2025 KAPA Chart by TradingView Kairos Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/06/2025$1.27$1.22-3.94%$1.29$1.21452,727 shs$25.30 million10/03/2025$1.15$1.27+10.43%$1.29$1.151.03 million shs$26.34 million10/02/2025$1.13$1.15+1.77%$1.18$1.11255,761 shs$23.85 million10/01/2025$1.17$1.13-3.42%$1.19$1.12316,826 shs$23.44 million09/30/2025$1.12$1.17+4.46%$1.18$1.12291,027 shs$24.27 million09/29/2025$1.10$1.12+1.82%$1.20$1.12360,558 shs$23.23 million09/26/2025$1.14$1.10-3.51%$1.14$1.06956,818 shs$22.81 million09/25/2025$1.20$1.14-5.00%$1.21$1.10699,445 shs$23.64 million09/24/2025$1.15$1.20+4.35%$1.25$1.16540,991 shs$24.89 million09/23/2025$1.15$1.15$1.25$1.14866,907 shs$23.85 million Get the Latest News and Ratings for KAPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. 09/22/2025$1.22$1.15-5.74%$1.23$1.11930,097 shs$23.85 million09/19/2025$1.34$1.22-8.96%$1.31$1.122.14 million shs$25.30 million09/18/2025$1.68$1.34-20.24%$1.47$1.215.46 million shs$27.79 million09/17/2025$1.61$1.68+4.35%$1.85$1.621.35 million shs$34.84 million09/16/2025$1.58$1.61+1.90%$1.63$1.48891,827 shs$33.39 million09/15/2025$1.76$1.58-10.23%$1.76$1.581.15 million shs$32.77 million09/12/2025$1.80$1.76-2.22%$1.82$1.67820,410 shs$36.50 million09/11/2025$1.85$1.80-2.70%$1.86$1.502.05 million shs$37.33 million09/10/2025$1.97$1.85-6.09%$2.10$1.831.09 million shs$38.37 million09/09/2025$1.85$1.97+6.49%$1.98$1.721.46 million shs$40.86 million09/08/2025$1.72$1.85+7.56%$2.11$1.733.78 million shs$38.37 million Related Companies Metagenomi Stock Chart Adagene Stock Chart Whitehawk Therapeutics Stock Chart Cardiol Therapeutics Stock Chart Pliant Therapeutics Stock Chart Invizyne Technologies Stock Chart Charlie's Stock Chart InflaRx Stock Chart Context Therapeutics Stock Chart Xtant Medical Stock Chart Receive KAPA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:KAPA) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kairos Pharma, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kairos Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
